Concepedia

Ronald R. Tuttle

RR

Statistics

Publications

13

Citations

1.1K

H-Index

12

Active since

1966

Affiliations

Eli Lilly (United States)(Current)

M. Tuttle & Associates

University of Tennessee Health Science Center

University of Miami

Ronald R. Tuttle is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1966–1995

13

Publications

13

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Ronald R. Tuttle, Jane Mills · Circulation Research · 1975 · 620 citations · Full text

, , +14

Nalmefene: Intravenous safety and kinetics of a new opioid antagonist

Ross Dixon, John F. Howes, Joseph Gentile et al. · Clinical Pharmacology & Therapeutics · 1986 · 98 citations

The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs.

Ronald R. Tuttle, G. Donald Pollock, Glen C. Todd et al. · Circulation Research · 1977 · 74 citations · Full text

The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs.

Chang‐seng Liang, N Imai, Charles K. Stone et al. · Circulation · 1987 · 58 citations · Full text

, , +22

Conditioning Effects of Chronic Infusions of Dobutamine

Chang‐seng Liang, Ronald R. Tuttle, William B. Hood et al. · Journal of Clinical Investigation · 1979 · 58 citations · Full text

1–5 of 13